Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Collaboration in Action: Chrystalina Antoniades

Strategic Developments

Chrystalina Antoniades is an Associate Professor of Clinical Neuroscience at the Nuffield Department of Clinical Neurosciences. In her story, Chrystalina shares her experience of collaboration and her top tips for successfully working with industry - ensuring mutual alignment and showcasing your passion.

Congratulations to Linxin Li

Awards and Honours Research Highlights

Who has been awarded a prestigious fellowship.

World Sleep Day

Events Public Engagement

Friday the 15th March marked World Sleep Day. To celebrate, we put on some fascinating, interactive public engagement events.

New online tool for child anxiety could expand access to child mental health services

Research Highlights

New research from the University of Oxford has revealed that an online programme that empowers parents to apply Cognitive Behavioural Therapy (CBT) principles in their child’s day to day lives is just as effective as traditional talking therapies for child anxiety problems.

Welcome Prof Shelley McKeown Jones

Research Highlights Strategic Developments

Fellow and Tutor in Experimental Psychology with Lady Margaret Hall joining us from Bristol

Prestigious prize for Asifa Majid

Awards and Honours

Our Professor of Cognitive Science, Asifa Majid, has been awarded the prestigious Elman prize

Virtual Reality technology to treat agoraphobia approved

Research Highlights

For the first time a virtual reality treatment (VR) has been recommended for use in NHS mental health services.

Farewell to the Le Gros Clark Building

Strategic Developments

We say goodbye to a building that has been central through our development as DPAG

Launch of innovative new study to tackle mental health inequalities

Research Highlights Strategic Developments

An innovative new study working with diverse people living with psychosis and other long-term physical health conditions.

Brain Health Innovation Summit

Events Strategic Developments

Where expertise meets innovation:a taskforce driving brain health research

Preventive Neurology Public Engagement Day

Public Engagement

Our team visited Templars Square shopping centre on Wednesday the 21st November 2023.

New survey reveals that a quarter of UK adults mistrust others

Research Highlights

A major new survey of trust and mistrust in the UK has revealed that a quarter of respondents mistrustful of other people.

Taking a statin at the same time as an antidepressant leads to better treatment adherence

New study by Oxford University shows that taking a statin at the same time as an antidepressant leads to better treatment adherence, which may be of importance to people with depression.

Professor Rebeccah Slater presented with Excellent Supervisor Award

Awards and Honours

Rebeccah Slater, Professor of Paediatric Neuroscience, Senior Wellcome Fellow and Chair of the Department of Paediatrics’ Equality, Diversity and Inclusivity Committee, has been presented with the Excellent Supervisor Award by the Head of the Medical Sciences Division (MSD).

Finnish Ambassador visits NDCN

International

NDCN hosted a networking event with a delegation from the Finnish embassy and a group of University of Oxford students from Finland.

Professor David M Clark joins Oxford Health as Non-Executive Director

Awards and Honours Strategic Developments

The Emeritus Professor of Experimental Psychology took up his role on 17 July 2023.

University of Oxford and Selvita collaborate to advance potential therapeutics for Parkinson's Disease

Strategic Developments

The University of Oxford and Selvita (WSE: SLV), one of the largest contract research organisations in Europe, are collaborating on drug discovery in the area of Parkinson's disease

Load More